Certified by Founder Lodge
Nextech Invest
Switzerland - Zurich
INVESTOR
1 Disclosed Funding Rounds $122,000,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive value
| Company | Date | Round | Raised |
|---|---|---|---|
 IDRx |
August, 02 ,2022 | Series A | $122,000,000 |
 Flare Therapeutics |
March, 23 ,2023 | Series B | $123,000,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
 Atavistik Bio |
December, 26 ,2023 | Unknown | $40,000,000 |
 FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
 Alterome Therapeutics, Inc |
April, 09 ,2024 | Series B | $132,000,000 |
 Delphia Therapeutics |
May, 07 ,2024 | Series A | $67,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Fabriclore | $1,600,000 | (Jul 2, 2024)
Waypoint Bio | $14,500,000 | (Jul 2, 2024)
K Health | $50,000,000 | (Jul 2, 2024)
Vytal | The reuse system | $6,644,850 | (Jul 2, 2024)
Pieces for Developers | $13,500,000 | (Jul 2, 2024)
